Predictors of low and very low bone mineral density in long‐term childhood acute lymphoblastic leukemia survivors: Toward personalized risk prediction

Abstract

AbstractBackgroundCohorts of childhood acute lymphoblastic leukemia (cALL) survivors reaching adulthood are increasing. Approximately 30% of survivors meet criteria for low bone mineral density (BMD) 10 years after diagnosis. We investigated risk factors for low BMD in long‐term cALL survivors.MethodsWe recruited 245 cALL survivors from the PETALE (Prévenir les effets tardifs des traitements de la leucémie aiguë lymphoblastique chez l'enfant) cohort, who were treated with the Dana Farber Cancer Institute protocols, did not experience disease relapse or hematopoietic stem cell transplants, and presented with more than 5 years of event‐free survival. Median time since diagnosis was 15.1 years.ResultsPrevalence of low DXA‐derived BMD (Z‐score ≤−1) ranged between 21.9% and 25.3%, depending on site (lumbar spine (LS‐BMD), femoral neck (FN‐BMD), and total body (TB‐BMD), and between 3.7% and 5.8% for very low BMD (Z‐score ≤−2). Males had a higher prevalence of low BMD than females for all three outcomes (26%–32% vs. 18%–21%), and male sex acted as a significant risk factor for low BMD in all models. Treatment‐related factors such as cumulative glucocorticoid (GC) doses and cranial radiation therapy (CRT) were associated with lower BMDs in the full cohort and in females at the FN‐BMD site.ConclusionLow and very low BMD is more prevalent in male cALL survivors. Male sex, high cumulative GC doses, CRT, risk group, and low body mass index (BMI) were identified as risk factors for low BMD. A longer follow‐up of BMD through time in these survivors is needed to establish if low BMD will translate into a higher risk for fragility fractures through adulthood.